| 1 | Parathyroid Neoplasms | 40.3% |
| 2 | Adrenal Gland Neoplasms | 31.7% |
| 3 | Multiple Endocrine Neoplasia | 27.8% |
| 4 | Pancreatic Neoplasm | 27.1% |
| 5 | Testicular Neoplasms | 24.6% |
| 6 | ovarian neoplasm | 22.8% |
| 7 | Abdominal Neoplasms | 20% |
| 8 | Soft Tissue Neoplasms | 20% |
| 9 | Thoracic Neoplasms | 20% |
| 10 | Pituitary Adenoma | 19.9% |
| 11 | Pituitary Neoplasms | 19.9% |
| 12 | Tracheal Neoplasms | 17.6% |
| 13 | Multiple Endocrine Neoplasia Type 1 | 17.5% |
| 14 | Prolactinoma | 17.4% |
| 15 | Growth Hormone-Secreting Pituitary Adenoma | 17.4% |
| 16 | Digestive System Neoplasms | 17.2% |
| 17 | Eye Neoplasms | 17.2% |
| 18 | Nervous System Neoplasms | 17.2% |
| 19 | Bone neoplasms | 16.9% |
| 20 | Skin Neoplasms | 16.9% |
| 21 | Hematologic Neoplasms | 16.9% |
| 22 | Mouth Neoplasms | 16.7% |
| 23 | Splenic Neoplasms | 16.7% |
| 24 | Euthyroid Sick Syndromes | 16% |
| 25 | Goiter | 16% |
| 26 | Hyperthyroidism | 16% |
| 27 | Hyperthyroxinemia | 16% |
| 28 | Hypothyroidism | 16% |
| 29 | Thyroiditis | 16% |
| 30 | Secondary hypothyroidism | 16% |
| 31 | Primary Hyperthyroidism | 16% |
| 32 | Primary Hypothyroidism | 16% |
| 33 | Carcinoma, Pancreatic Ductal | 15.9% |
| 34 | Esophageal Neoplasms | 15.4% |
| 35 | Peritoneal Neoplasms | 15.1% |
| 36 | Adrenocortical carcinoma | 15.1% |
| 37 | granulosa cell tumor | 14.9% |
| 38 | Carcinoma, Ovarian Epithelial | 14.9% |
| 39 | Endocrine Gland Neoplasms | 14.4% |
| 40 | Adrenal Gland Diseases | 13.7% |
| 41 | Gonadal Disorders | 13.7% |
| 42 | Parathyroid Diseases | 13.7% |
| 43 | Paraneoplastic Encephalomyelitis | 13.5% |
| 44 | Nelson Syndrome | 13.3% |
| 45 | Graves Disease | 13.3% |
| 46 | Mammary Neoplasms, Experimental | 13.3% |
| 47 | Thyroid Neoplasm | 12.6% |
| 48 | Thyroid carcinoma | 12.6% |
| 49 | insulinoma | 12.6% |
| 50 | Gastrinoma | 12.4% |
| 51 | Glucagonoma | 12.4% |
| 52 | Leydig Cell Tumor | 12.4% |
| 53 | Hamartoma | 12.3% |
| 54 | Neoplasms, Hormone-Dependent | 12.3% |
| 55 | Neoplasms, Multiple Primary | 12.3% |
| 56 | Paraneoplastic Syndromes | 12.3% |
| 57 | Precancerous Conditions | 12.3% |
| 58 | Neoplasms, Second Primary | 12.3% |
| 59 | Acanthoma | 12% |
| 60 | Vipoma | 12% |
| 61 | Retroperitoneal Neoplasms | 11.8% |
| 62 | Bone Diseases, Endocrine | 11.5% |
| 63 | Diabetes Mellitus | 11.4% |
| 64 | Pituitary Diseases | 11.3% |
| 65 | Leukoplakia, Oral | 10.7% |
| 66 | Thyrotoxicosis | 10.5% |
| 67 | Thyroid Hormone Resistance Syndrome | 10.5% |
| 68 | Cyst | 10.3% |
| 69 | Neoplastic Processes | 10.3% |
| 70 | Neoplastic Syndromes, Hereditary | 10.3% |
| 71 | Pregnancy Complications, Neoplastic | 10.3% |
| 72 | Congenital Hypothyroidism | 10.3% |
| 73 | Neoplasms, Experimental | 10.2% |
| 74 | Carcinoma, Lobular | 10.2% |
| 75 | Head and Neck Neoplasms | 10% |
| 76 | Central Nervous System Neoplasms | 10% |
| 77 | Vascular Neoplasms | 10% |
| 78 | Thymus Neoplasms | 10% |
| 79 | Genital Neoplasms, Female | 9.9% |
| 80 | Breast Neoplasms, Male | 9.8% |
| 81 | Triple Negative Breast Neoplasms | 9.8% |
| 82 | Dwarfism | 9.8% |
| 83 | Nose Neoplasms | 9.8% |
| 84 | Ear Neoplasms | 9.6% |
| 85 | Eyelid Neoplasms | 9.6% |
| 86 | Palatal Neoplasms | 9.5% |
| 87 | Salivary Gland Neoplasms | 9.4% |
| 88 | Tongue Neoplasms | 9.4% |
| 89 | Autoimmune thyroiditis | 8.9% |
| 90 | Myxedema | 8.8% |
| 91 | Neoplasms, Radiation-Induced | 8.8% |
| 92 | Gastrointestinal Neoplasms | 8.7% |
| 93 | Genital Neoplasms, Male | 8.7% |
| 94 | Liver neoplasms | 8.7% |
| 95 | Uveal Neoplasms | 8.7% |
| 96 | Meningioma | 8.6% |
| 97 | Urologic Neoplasms | 8.6% |
| 98 | Corpus Luteum Cyst | 8.5% |
| 99 | Ovarian Cysts | 8.5% |
| 100 | Sebaceous Gland Neoplasms | 8.5% |
| 101 | Spinal Neoplasms | 8.5% |
| 102 | Bone Marrow Neoplasms | 8.5% |
| 103 | Thymoma | 8.5% |
| 104 | Pharyngeal Neoplasms | 8.4% |
| 105 | Thyroid Nodule | 8.2% |
| 106 | Liver Neoplasms, Experimental | 8.1% |
| 107 | Adrenal Cortex Diseases | 8% |
| 108 | Carcinoma 256, Walker | 8% |
| 109 | Hyperparathyroidism | 8% |
| 110 | Hypogonadism | 8% |
| 111 | Hypoparathyroidism | 8% |
| 112 | Delayed Puberty | 8% |
| 113 | Precocious Puberty | 8% |
| 114 | Hypogonadotropic hypogonadism | 8% |
| 115 | Testotoxicosis | 8% |
| 116 | Hashimoto Disease | 7.8% |
| 117 | Tuberous Sclerosis | 7.8% |
| 118 | Carcinoma, Ehrlich Tumor | 7.7% |
| 119 | Dermoid Cyst | 7.7% |
| 120 | Carcinoma, Lewis Lung | 7.7% |
| 121 | Trophoblastic Neoplasms | 7.6% |
| 122 | Leukemia, Experimental | 7.6% |
| 123 | Laryngeal neoplasm | 7.5% |
| 124 | Paraneoplastic Cerebellar Degeneration | 7.4% |
| 125 | Acoustic Neuroma | 7.1% |
| 126 | Melanoma, Experimental | 6.9% |
| 127 | Thyroid Diseases | 6.8% |
| 128 | Nephroblastoma | 6.8% |
| 129 | Testicular Diseases | 6.7% |
| 130 | Leukemia, Radiation-Induced | 6.7% |
| 131 | Erythroplasia | 6.7% |
| 132 | Follicular cyst | 6.7% |
| 133 | leukemia | 6.7% |
| 134 | Mucocele | 6.7% |
| 135 | Neoplasms, Germ Cell and Embryonal | 6.7% |
| 136 | Neoplasms, Glandular and Epithelial | 6.7% |
| 137 | Pilonidal Cyst | 6.7% |
| 138 | Thyroglossal Cyst | 6.7% |
| 139 | Synovial Cyst | 6.7% |
| 140 | Germ Cell Cancer | 6.7% |
| 141 | Aberrant Crypt Foci | 6.7% |
| 142 | Ovarian Diseases | 6.6% |
| 143 | Empty Sella Syndrome | 6.6% |
| 144 | Hyperpituitarism | 6.6% |
| 145 | Hypopituitarism | 6.6% |
| 146 | Hypophysitis | 6.6% |
| 147 | Sarcoma, Experimental | 6.6% |
| 148 | Neuroectodermal Tumors | 6.6% |
| 149 | Retinoblastoma | 6.6% |
| 150 | Meningeal Neoplasms | 6.6% |
| 151 | Hepatocellular Adenoma | 6.6% |
| 152 | Limbic Encephalitis | 6.5% |
| 153 | Neoplasms, Neuroepithelial | 6.5% |
| 154 | Gliomatosis cerebri | 6.5% |
| 155 | Hypopharyngeal Neoplasms | 6.2% |
| 156 | Hypopharyngeal Cancer | 6.2% |
| 157 | Parotid Neoplasms | 6.1% |
| 158 | Lambert-Eaton Myasthenic Syndrome | 6% |
| 159 | Lung Neoplasms | 5.7% |
| 160 | Pleural Neoplasms | 5.7% |
| 161 | Gestational Diabetes | 5.7% |
| 162 | Latent Autoimmune Diabetes in Adults | 5.7% |
| 163 | Diabetes Insipidus | 5.7% |
| 164 | Diabetes Mellitus, Experimental | 5.7% |
| 165 | Optic Nerve Glioma | 5.6% |
| 166 | Brain Neoplasms | 5.6% |
| 167 | Spinal Cord Neoplasms | 5.6% |
| 168 | Leukoplakia | 5.6% |
| 169 | Lymphocele | 5.6% |
| 170 | Pancreatic Cyst | 5.6% |
| 171 | Polycystic Ovary Syndrome | 5.6% |
| 172 | melanoma | 5.6% |
| 173 | Uterine Neoplasms | 5.6% |
| 174 | Vaginal Neoplasms | 5.6% |
| 175 | Vulvar Neoplasms | 5.6% |
| 176 | Uterine Cancer | 5.6% |
| 177 | Fallopian Tube Neoplasms | 5.6% |
| 178 | Barrett Esophagus | 5.6% |
| 179 | Breast Cyst | 5.6% |
| 180 | Histiocytic Disorders, Malignant | 5.6% |
| 181 | Actinic keratosis | 5.6% |
| 182 | Mediastinal Cyst | 5.6% |
| 183 | Neoplasm Invasiveness | 5.6% |
| 184 | Neoplasm Metastasis | 5.6% |
| 185 | Neoplasm Recurrence, Local | 5.6% |
| 186 | Parovarian Cyst | 5.6% |
| 187 | Pericardial Cyst | 5.6% |
| 188 | Thymic Cyst | 5.6% |
| 189 | Carcinogenesis | 5.6% |
| 190 | Myxoid cyst | 5.6% |
| 191 | Metastasis | 5.6% |
| 192 | Carcinosarcoma | 5.5% |
| 193 | Hemangiosarcoma | 5.5% |
| 194 | Leukemia L1210 | 5.5% |
| 195 | Leukemia P388 | 5.5% |
| 196 | lymphangiosarcoma | 5.5% |
| 197 | Opsoclonus-Myoclonus Syndrome | 5.4% |
| 198 | Lymphomatoid Granulomatosis | 5.3% |
| 199 | Carcinoma, Endometrioid | 5.3% |
| 200 | Choriocarcinoma | 5.3% |
| 201 | Cushing Syndrome | 5.3% |
| 202 | Hyperaldosteronism | 5.3% |
| 203 | Hyperparathyroidism, Secondary | 5.3% |
| 204 | Hypoaldosteronism | 5.3% |
| 205 | Hyperparathyroidism, Primary | 5.3% |
| 206 | Medulloblastoma | 5.1% |
| 207 | Adenomatous Polyposis Coli | 5.1% |
| 208 | Tonsillar Neoplasms | 5.1% |
| 209 | Hermaphroditism | 5% |
| 210 | Disorders of Sex Development | 5% |
| 211 | Central Nervous System Cysts | 5% |
| 212 | Nasopharyngeal Neoplasms | 4.9% |
| 213 | Bile Duct Neoplasms | 4.9% |
| 214 | gallbladder neoplasm | 4.9% |
| 215 | Intestinal Neoplasms | 4.9% |
| 216 | Penile Neoplasms | 4.9% |
| 217 | Prostatic Neoplasms | 4.9% |
| 218 | Stomach Neoplasms | 4.9% |
| 219 | Myelitis, Transverse | 4.9% |
| 220 | Pituitary Apoplexy | 4.9% |
| 221 | Composite Lymphoma | 4.9% |
| 222 | Sarcoma 180 | 4.9% |
| 223 | Diabetic Foot | 4.9% |
| 224 | Polycythemia Vera | 4.9% |
| 225 | Meningeal Carcinomatosis | 4.9% |
| 226 | Mesoblastic Nephroma | 4.9% |
| 227 | Nasopharyngeal carcinoma | 4.9% |
| 228 | Basal Cell Nevus Syndrome | 4.8% |
| 229 | Lymphoma | 4.8% |
| 230 | Denys-Drash Syndrome | 4.7% |
| 231 | Leukemia, Plasma Cell | 4.7% |
| 232 | Adenoma, Acidophil | 4.6% |
| 233 | Ganglioneuroma | 4.6% |
| 234 | Glioma | 4.6% |
| 235 | Malignant Glioma | 4.6% |
| 236 | Kallmann Syndrome | 4.6% |
| 237 | Paranasal Sinus Neoplasms | 4.5% |
| 238 | Addison Disease | 4.4% |
| 239 | Diabetic Angiopathies | 4.4% |
| 240 | Primary Adrenal Insufficiency | 4.4% |
| 241 | Diabetic Neuropathies | 4.4% |
| 242 | Orchitis | 4.4% |
| 243 | Diabetic Amyotrophy | 4.4% |
| 244 | Diabetic Autonomic Neuropathy | 4.4% |
| 245 | Diabetic Cardiomyopathies | 4.4% |
| 246 | Bladder Neoplasm | 4.4% |
| 247 | Kidney Neoplasm | 4.4% |
| 248 | Ureteral Neoplasms | 4.4% |
| 249 | Urethral Neoplasms | 4.4% |
| 250 | Ovarian Hyperstimulation Syndrome | 4.4% |
| 251 | Hyperprolactinemia | 4.4% |
| 252 | Basal cell carcinoma | 4.3% |
| 253 | Carcinoma, Papillary | 4.3% |
| 254 | Squamous cell carcinoma | 4.3% |
| 255 | Chondrosarcoma | 4.3% |
| 256 | Craniopharyngioma | 4.3% |
| 257 | Cystadenoma | 4.3% |
| 258 | leiomyosarcoma | 4.3% |
| 259 | liposarcoma | 4.3% |
| 260 | Mesothelioma | 4.3% |
| 261 | synovial sarcoma | 4.3% |
| 262 | Neuroectodermal Tumor, Melanotic | 4.3% |
| 263 | Angiomyolipoma | 4.3% |
| 264 | Clear Cell Sarcoma of Soft Tissue | 4.3% |
| 265 | Alveolar Soft Part Sarcoma | 4.3% |
| 266 | Neuroendocrine Tumors | 4.3% |
| 267 | Sarcoma, Myeloid | 4.3% |
| 268 | Carcinoma, Basal Cell | 4.3% |
| 269 | Bronchial Neoplasms | 4.3% |
| 270 | Multiple Pulmonary Nodules | 4.2% |
| 271 | Choledochal Cyst | 4.2% |
| 272 | Supratentorial Neoplasms | 4.2% |
| 273 | Carcinoid Tumor | 4.2% |
| 274 | Endometrial Neoplasms | 4.2% |
| 275 | Neurilemmoma | 4.2% |
| 276 | Hutchinson's Melanotic Freckle | 4.2% |
| 277 | Melanoma, Amelanotic | 4.2% |
| 278 | Peutz-Jeghers Syndrome | 4.1% |
| 279 | Klinefelter Syndrome | 4.1% |
| 280 | Adenoma | 3.9% |
| 281 | Ameloblastoma | 3.9% |
| 282 | Angiokeratoma | 3.9% |
| 283 | Carcinoma | 3.9% |
| 284 | Chordoma | 3.9% |
| 285 | Hemangioma | 3.9% |
| 286 | hemangiopericytoma | 3.9% |
| 287 | Lymphangioma | 3.9% |
| 288 | Mesenchymoma | 3.9% |
| 289 | Nevus | 3.9% |
| 290 | Teratoma | 3.9% |
| 291 | Hepatoblastoma | 3.9% |
| 292 | Mixed Tumor, Mullerian | 3.9% |
| 293 | Germinoma | 3.9% |
| 294 | Teratocarcinoma | 3.9% |
| 295 | Angiofibroma | 3.9% |
| 296 | Sarcoma | 3.9% |
| 297 | Epithelioma | 3.9% |
| 298 | Hyperglycemic Hyperosmolar Nonketotic Coma | 3.9% |
| 299 | Renal Cell Carcinoma | 3.9% |
| 300 | Papillary Renal Cell Carcinoma | 3.9% |
| 301 | Cystadenocarcinoma | 3.8% |
| 302 | Fibrosarcoma | 3.8% |
| 303 | Osteosarcoma | 3.8% |
| 304 | Mucoepidermoid Carcinoma | 3.8% |
| 305 | Gigantism | 3.8% |
| 306 | Diabetic Nephropathy | 3.8% |
| 307 | Acromegaly | 3.7% |
| 308 | Anovulation | 3.7% |
| 309 | Diabetic Ketoacidosis | 3.7% |
| 310 | Oophoritis | 3.7% |
| 311 | Pleural Effusion, Malignant | 3.7% |
| 312 | Astrocytoma | 3.7% |
| 313 | Ependymoma | 3.7% |
| 314 | oligodendroglioma | 3.7% |
| 315 | Ganglioglioma | 3.7% |
| 316 | gliosarcoma | 3.7% |
| 317 | Anaplastic astrocytoma | 3.7% |
| 318 | Anaplastic Oligodendroglioma | 3.7% |
| 319 | Maxillary Sinus Neoplasms | 3.7% |
| 320 | Prostatic Neoplasms, Castration-Resistant | 3.7% |
| 321 | Endometrial Stromal Sarcoma | 3.6% |
| 322 | Adenofibroma | 3.5% |
| 323 | Fibroadenoma | 3.5% |
| 324 | Malignant Fibrous Histiocytoma | 3.5% |
| 325 | Brain Stem Neoplasms | 3.5% |
| 326 | Malignant Carcinoid Syndrome | 3.5% |
| 327 | Cryptorchidism | 3.3% |
| 328 | Pancreatic Pseudocyst | 3.3% |
| 329 | Plasmacytoma | 3.3% |
| 330 | Gonadal Dysgenesis | 3.3% |
| 331 | Malignant histiocytosis | 3.3% |
| 332 | Lymphatic Metastasis | 3.3% |
| 333 | Neoplasms, Unknown Primary | 3.3% |
| 334 | Leukemic Infiltration | 3.3% |
| 335 | Adrenogenital Syndrome | 3.3% |
| 336 | Histiocytic sarcoma | 3.3% |
| 337 | Neoplasm Micrometastasis | 3.3% |
| 338 | Ovotesticular Disorders of Sex Development | 3.3% |
| 339 | Lymphangioleiomyomatosis | 3.3% |
| 340 | Bowen's Disease | 3.2% |
| 341 | Cecal Neoplasms | 3.2% |
| 342 | Duodenal Neoplasms | 3.2% |
| 343 | Paraganglioma | 3.2% |
| 344 | Rhabdomyosarcoma | 3.2% |
| 345 | Giant Cell Tumor of Bone | 3.2% |
| 346 | Hydatidiform Mole | 3.2% |
| 347 | Hyperandrogenism | 3.2% |
| 348 | Glioblastoma | 3.2% |
| 349 | Neuroblastoma | 3.2% |
| 350 | Glioblastoma Multiforme | 3.2% |
| 351 | Choroid Plexus Papilloma | 3.1% |
| 352 | Neurofibrosarcoma | 3% |
| 353 | Cerebellar Neoplasms | 3% |
| 354 | Ganglioneuroblastoma | 3% |
| 355 | Dermatofibrosarcoma | 3% |
| 356 | Dermatofibrosarcoma Protuberans | 3% |
| 357 | Colorectal Neoplasms | 2.9% |
| 358 | Diabetic Retinopathy | 2.8% |
| 359 | Hodgkin Disease | 2.8% |
| 360 | Lymphoma, Non-Hodgkin | 2.8% |
| 361 | Xeroderma Pigmentosum | 2.8% |
| 362 | Carcinoid Heart Disease | 2.7% |
| 363 | Pheochromocytoma | 2.7% |
| 364 | Alveolar rhabdomyosarcoma | 2.7% |
| 365 | Appendiceal Neoplasms | 2.7% |
| 366 | Colonic Neoplasms | 2.7% |
| 367 | Rectal Neoplasms | 2.7% |
| 368 | Adenocarcinoma | 2.6% |
| 369 | Carcinoma in Situ | 2.6% |
| 370 | Carcinoma, Transitional Cell | 2.6% |
| 371 | Phyllodes Tumor | 2.6% |
| 372 | Dysgerminoma | 2.6% |
| 373 | Hemangioendothelioma | 2.6% |
| 374 | Lipoma | 2.6% |
| 375 | Myoma | 2.6% |
| 376 | Myxoma | 2.6% |
| 377 | Neuroma | 2.6% |
| 378 | Papilloma | 2.6% |
| 379 | Pseudomyxoma Peritonei | 2.6% |
| 380 | Seminoma | 2.6% |
| 381 | Papillomatosis | 2.6% |
| 382 | Angiolipoma | 2.6% |
| 383 | Myelolipoma | 2.6% |
| 384 | Neoplasms, Bone Tissue | 2.6% |
| 385 | Neoplasms, Fibrous Tissue | 2.6% |
| 386 | Smooth Muscle Tumor | 2.6% |
| 387 | Adenomatosis, Pulmonary | 2.6% |
| 388 | Adenomatous Polyps | 2.6% |
| 389 | Carcinoma, Large Cell | 2.6% |
| 390 | Carcinoma, Small Cell | 2.6% |
| 391 | Desmoplastic Small Round Cell Tumor | 2.6% |
| 392 | Chondroma | 2.6% |
| 393 | Enchondroma | 2.6% |
| 394 | Primary amyloidosis | 2.5% |
| 395 | Turner Syndrome | 2.3% |
| 396 | Leukemia, Myelomonocytic, Chronic | 2.2% |
| 397 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2.2% |
| 398 | Anus Neoplasms | 2.2% |
| 399 | Sigmoid Neoplasms | 2.2% |
| 400 | Waterhouse-Friderichsen Syndrome | 2% |
| 401 | Waldenstrom Macroglobulinemia | 2% |
| 402 | Multiple Myeloma | 2% |
| 403 | Adenoid Cystic Carcinoma | 2% |
| 404 | fibroma | 2% |
| 405 | Fibromatosis | 2% |
| 406 | Osteoblastoma | 2% |
| 407 | Osteoma | 2% |
| 408 | Rhabdomyoma | 2% |
| 409 | Chondromatosis | 2% |
| 410 | Adenocarcinoma, Clear Cell | 2% |
| 411 | Cholangiocarcinoma | 2% |
| 412 | Cervical Intraepithelial Neoplasia | 2% |
| 413 | Hemangioblastoma | 2% |
| 414 | Lymphoma, Extranodal NK-T-Cell | 2% |
| 415 | Mastocytosis | 1.9% |
| 416 | Sturge-Weber Syndrome | 1.9% |
| 417 | Cell Transformation, Viral | 1.9% |
| 418 | Gastrointestinal Stromal Tumors | 1.9% |
| 419 | Hemangioma, Cavernous | 1.9% |
| 420 | Leukemia, T-Cell | 1.9% |
| 421 | Leukemia, B-Cell | 1.9% |
| 422 | neurofibroma | 1.9% |
| 423 | Lymphoma, Follicular | 1.9% |
| 424 | T-Cell Lymphoma | 1.9% |
| 425 | Mantle cell lymphoma | 1.9% |
| 426 | Zollinger-Ellison syndrome | 1.8% |
| 427 | Renal Osteodystrophy | 1.8% |
| 428 | Renal rickets | 1.8% |
| 429 | Mastocytoma | 1.6% |
| 430 | Fibromatosis, Aggressive | 1.6% |
| 431 | Fibromatosis, Abdominal | 1.6% |
| 432 | Klatskin Tumor | 1.6% |
| 433 | Mastocytosis, Systemic | 1.6% |
| 434 | Leukemia, Myeloid, Chronic-Phase | 1.6% |
| 435 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.4% |
| 436 | Leukemia, Large Granular Lymphocytic | 1.4% |
| 437 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.4% |
| 438 | Lymphoma, T-Cell, Cutaneous | 1.4% |
| 439 | Lymphoma, AIDS-Related | 1.4% |
| 440 | Enteropathy-Associated T-Cell Lymphoma | 1.4% |
| 441 | Primary Effusion Lymphoma | 1.4% |
| 442 | Adrenoleukodystrophy | 1.3% |
| 443 | Dupuytren Contracture | 1.2% |
| 444 | Urticaria Pigmentosa | 1.2% |
| 445 | Mycosis Fungoides | 1.1% |
| 446 | Lymphomatoid Papulosis | 1.1% |
| 447 | Plasmablastic lymphoma | 1.1% |
| 448 | Burkitt Lymphoma | 1.1% |
| 449 | Sezary Syndrome | 0.9% |
| 450 | Radicular Cyst | 0.9% |
